Lawrence Blacher, M.D., Memorial Lecture Evaluation - April 16, 2026

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Describe current and emerging diagnostic and imaging strategies in the diagnosis of amyloid cardiomyopathy	Describe current and emerging diagnostic and imaging strategies in the diagnosis of amyloid cardiomyopathy - 5	Describe current and emerging diagnostic and imaging strategies in the diagnosis of amyloid cardiomyopathy - 4	Describe current and emerging diagnostic and imaging strategies in the diagnosis of amyloid cardiomyopathy - 3	Describe current and emerging diagnostic and imaging strategies in the diagnosis of amyloid cardiomyopathy - 2	Describe current and emerging diagnostic and imaging strategies in the diagnosis of amyloid cardiomyopathy - 1
Apply supportive management strategies for the care of patients with amyloid cardiomyopathy	Apply supportive management strategies for the care of patients with amyloid cardiomyopathy - 5	Apply supportive management strategies for the care of patients with amyloid cardiomyopathy - 4	Apply supportive management strategies for the care of patients with amyloid cardiomyopathy - 3	Apply supportive management strategies for the care of patients with amyloid cardiomyopathy - 2	Apply supportive management strategies for the care of patients with amyloid cardiomyopathy - 1
Evaluate current and emerging disease-modifying therapies for amyloid cardiomyopathy	Evaluate current and emerging disease-modifying therapies for amyloid cardiomyopathy - 5	Evaluate current and emerging disease-modifying therapies for amyloid cardiomyopathy - 4	Evaluate current and emerging disease-modifying therapies for amyloid cardiomyopathy - 3	Evaluate current and emerging disease-modifying therapies for amyloid cardiomyopathy - 2	Evaluate current and emerging disease-modifying therapies for amyloid cardiomyopathy - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
Apply current multimodality imaging and biomarker approaches to accurately diagnose and differentiate subtypes of cardiac amyloidosis.	Apply current multimodality imaging and biomarker approaches to accurately diagnose and differentiate subtypes of cardiac amyloidosis. - 5	Apply current multimodality imaging and biomarker approaches to accurately diagnose and differentiate subtypes of cardiac amyloidosis. - 4	Apply current multimodality imaging and biomarker approaches to accurately diagnose and differentiate subtypes of cardiac amyloidosis. - 3	Apply current multimodality imaging and biomarker approaches to accurately diagnose and differentiate subtypes of cardiac amyloidosis. - 2	Apply current multimodality imaging and biomarker approaches to accurately diagnose and differentiate subtypes of cardiac amyloidosis. - 1
Implement management strategies to optimize symptom control and quality of life in patients with cardiac amyloidosis.	Implement management strategies to optimize symptom control and quality of life in patients with cardiac amyloidosis. - 5	Implement management strategies to optimize symptom control and quality of life in patients with cardiac amyloidosis. - 4	Implement management strategies to optimize symptom control and quality of life in patients with cardiac amyloidosis. - 3	Implement management strategies to optimize symptom control and quality of life in patients with cardiac amyloidosis. - 2	Implement management strategies to optimize symptom control and quality of life in patients with cardiac amyloidosis. - 1
Select appropriate disease-modifying therapies based on amyloid subtype and individual patient characteristics.	Select appropriate disease-modifying therapies based on amyloid subtype and individual patient characteristics. - 5	Select appropriate disease-modifying therapies based on amyloid subtype and individual patient characteristics. - 4	Select appropriate disease-modifying therapies based on amyloid subtype and individual patient characteristics. - 3	Select appropriate disease-modifying therapies based on amyloid subtype and individual patient characteristics. - 2	Select appropriate disease-modifying therapies based on amyloid subtype and individual patient characteristics. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

How did you hear about this course? *

Name

You are here

Lawrence Blacher, M.D., Memorial Lecture Evaluation - April 16, 2026